IFIT3 and COVID-19: In line with the single-cell study, signs of an interferon response were observed irrespective of disease severity (IFIT1, IFIT3), while only severe COVID-19 patients’ granulocytes featured expression of genes with suppressive functionality, such as ARG1 or CD274 (PD-L1) (Fig. 3f).